Xtant Medical shares decreased 0.38 percent in short interest, according to Business Standard Tribune.
Here are three facts:
1. In February, Xtant Medical's total short interest was 78,300 shares, down from 78,600 shares.
2. Since July, the shares have declined nearly 19.7 percent.
3. Xtant Medical's shares have underperformed the S&P 500 by 11.04 percent.
More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune's 15 best workplaces for production: 4 things to know